Philip Cruz

Country Medical Director at Moderna UK, Dr Philip Cruz, has over 15 years of experience in medical affairs in the field of vaccines and paediatrics within the pharmaceutical industry. At Moderna in the UK, Dr Cruz is responsible for the development and execution of the medical affairs strategy for Moderna’s infectious disease franchise and drives scientific leadership for the vaccine portfolio, while ensuring compliance with applicable policies and procedures. He also ensures effective interactions with key UK scientific leaders, public health experts, scientific and medical associations and healthcare authorities at the national level, providing country insight-gathering activities to meet the company needs around the clinical development and innovation in the field of vaccination.

Dr Cruz worked at GSK Vaccines for over 11 years, eventually assuming the role of Vaccines Medical Director for the UK and Ireland. Following his time at GSK, he was appointed as Senior Global Medical Affairs Leader (Vaccines) at AstraZeneca. He has a breadth of experience in clinical development and continues his involvement in clinical trials as a local medical lead. His role as an ABPI final signatory has given him established knowledge in medical governance and he has extensive experience in pharmaceutical medical affairs.

A paediatrician by training, Dr Cruz is actively involved in clinical research, research and development and pharmaceutical medicine.